"Sarcoma, Kaposi" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
Descriptor ID |
D012514
|
MeSH Number(s) |
C02.256.466.860 C04.557.450.795.850 C04.557.645.750
|
Concept/Terms |
Sarcoma, Kaposi- Sarcoma, Kaposi
- Kaposi's Sarcoma
- Kaposis Sarcoma
- Sarcoma, Kaposi's
- Multiple Idiopathic Pigmented Hemangiosarcoma
- Kaposi Sarcoma
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma, Kaposi".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma, Kaposi".
This graph shows the total number of publications written about "Sarcoma, Kaposi" by people in this website by year, and whether "Sarcoma, Kaposi" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2003 | 3 | 0 | 3 |
2008 | 1 | 1 | 2 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 3 | 0 | 3 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2020 | 3 | 0 | 3 |
2021 | 1 | 0 | 1 |
2022 | 4 | 0 | 4 |
2023 | 3 | 0 | 3 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma, Kaposi" by people in Profiles.
-
Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067. J Acquir Immune Defic Syndr. 2024 Nov 01; 97(3):216-225.
-
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2023 10 01; 94(2):165-173.
-
Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study. Clin Infect Dis. 2023 04 17; 76(8):1440-1448.
-
Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout. Int J Cancer. 2023 05 15; 152(10):2081-2089.
-
Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995-2016). Int J Cancer. 2023 01 15; 152(2):183-194.
-
Epidemiology of Kaposi's sarcoma in sub-Saharan Africa. Cancer Epidemiol. 2022 Jun; 78:102167.
-
Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort. BMJ Open. 2022 04 11; 12(4):e053460.
-
Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: A case-control study. Cancer Epidemiol. 2022 Jun; 78:102158.
-
Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study. BMJ Open. 2021 10 18; 11(10):e043941.
-
The impact of the South African antiretroviral treatment programme on the age-standardised incidence rate of Kaposi sarcoma, 1999-2016: An interrupted time series analysis. Int J Infect Dis. 2021 Jan; 102:20-27.